ACTUATE THERAPEUTICS, INC. (ACTU) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-05-22

ACTUATE THERAPEUTICS, INC. (ACTU) has filed 7 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-05-22. 3 Form 8-K material event filings were reported by ACTU in the last 90 days. InsiderAlpha tracks every ACTU SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About ACTUATE THERAPEUTICS, INC. (ACTU)

SEC CIK	0001652935

90-Day SEC Filing Activity

Form 4 filings (90d)	7
Form 8-K filings (90d)	3
Latest Form 4 filing	2026-05-22

Recent ACTU Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-02-13	SCHMITT DANIEL M	President, CEO and Director	M — Option exercise	272.1K	$0.00	—	SEC
2026-02-13	SCHMITT DANIEL M	President, CEO and Director	F — Tax withholding / forfeiture	121.9K	$4.33	$528K	SEC
2026-01-05	THOMSON TODD S	Insider	S — Open-market sale	280.0K	$5.80	$1.62M	SEC

All transactions sourced from SEC EDGAR Form 4 filings for ACTUATE THERAPEUTICS, INC. (ACTU). Updated in real time as new filings are submitted to the SEC.

Most-Active ACTU Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
Huber Martin H. Jr.	1	—
Sawhney Roger	1	—
Fletcher Aaron G.L.	1	—
THOMSON TODD S	1	—
Keyes Jason A	1	—

Recent ACTU Form 8-K Material Events

2026-05-22 — Item 5.07 [SEC]
2026-05-11 — Item 7.01, 9.01 [SEC]
2026-05-06 — Item 5.02, 8.01, 9.01 [SEC]

Recent Insider Filings

2026-05-22 — Zabrowski Dan (Director)
2026-05-22 — THOMSON TODD S (Director)
2026-05-22 — Sawhney Roger (Director)
2026-05-22 — RONNEBERG AMY L (Director)
2026-05-22 — Keyes Jason A (Director)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in ACTU insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

ACTU Insider Trading — FAQ

What is the latest insider trade for ACTU?: ACTUATE THERAPEUTICS, INC. (ACTU) had 7 insider filings in the last 90 days, with the most recent on 2026-05-22. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying ACTU stock?: 0 insider purchases of ACTU were filed in the last 90 days.
How many insiders are selling ACTU stock?: 0 insider sales of ACTU were filed in the last 90 days.
Where can I see ACTU SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every ACTU SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live ACTU dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.